BackIntercept Pharmaceuticals Overview
Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Target Price

Explore Intercept Pharmaceuticals's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$19

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2023-07-13H.C. WainwrightEd Arce$190% upsideOpen
2023-06-29Canaccord GenuityEdward Nash$190% upsideOpen
2022-11-16H.C. Wainwright$1426.3% downsideOpen
2022-10-03Mizuho SecuritiesAnthony Crowdell$2742.1% upsideOpen
2021-11-04Raymond JamesSteven Seedhouse$44131.6% upsideOpen
2021-11-04BMO CapitalMatthew Luchini$2215.8% upsideOpen
2021-10-15JefferiesMichael Yee$190% upsideOpen
2021-08-20Goldman SachsSalveen Richter$1047.4% downsideOpen
2021-05-07Cantor FitzgeraldAlethia Young$2321.1% upsideOpen
2021-05-06Wells FargoDerek Archila$1615.8% downsideOpen

Intercept Pharmaceuticals (ICPT) FAQ

Stockcircle tracks target price for Intercept Pharmaceuticals (ICPT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Intercept Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ICPT overview so you can move from this figure to the surrounding analysis quickly.